Seattle Genetics Inc. (SGEN)

Last Three Months

02-Nov-22 -- 01-Feb-23

Time Period:

Three Months
|
Year

($1.19M) Net Amount

Buy:	0	--
Sell:	($1.19M)	$127.63 - $130.71

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

1

(2)

0

(1)

43

0

3

+1

0

+2

0

+3

Two Year Chart

02-Feb-21 -- 01-Feb-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Nov-22 5:46 PM View:	11-Nov-22 Market Sale ($968.22K)	Gryska David W Director		Seattle Genetics Inc. - SGEN	(16%) 47.75K to 40.25K	0	($968.22K) (16%)	--	$129.10	Show Txns Hide Txns

14-Dec-22 5:49 PM View:	12-Dec-22 Option Exercise $321.12K	Simonian Nancy A Director		Seattle Genetics Inc. - SGEN	16% 54.0K to 62.75K	0	0	--	--	Show Txns Hide Txns

26-Jan-23 7:39 PM View:	24-Jan-23 Planned Option Sale ($675.13K)	Liu Jean I Chief Legal Officer		Seattle Genetics Inc. - SGEN	1% 84.39K to 85.11K	0	($75.55K) (1%)	--	$130.71	Show Txns Hide Txns

14-Nov-22 5:45 PM View:	09-Nov-22 Grant 0	Epstein David R Chief Executive Officer Director		Seattle Genetics Inc. - SGEN	100% 0 to 107.39K	0	0	--	--	Show Txns Hide Txns

14-Nov-22 6:24 PM View:	09-Nov-22 Grant 0	Swain Sandra M Director		Seattle Genetics Inc. - SGEN	100% 0 to 0.78K	0	0	--	--	Show Txns Hide Txns

21-Dec-22 6:48 PM View:	20-Dec-22 Market Sale (Planned) ($144.09K)	Romp Charles R EVP, Commercial U.S.		Seattle Genetics Inc. - SGEN	(2%) 59.6K to 58.48K	0	($144.09K) (2%)	--	$127.63	Show Txns Hide Txns

26-Jan-23 7:41 PM View:	24-Jan-23 Planned Option Sale ($1.35M)	Dansey Roger D President, R&D & CMO		Seattle Genetics Inc. - SGEN	0% 97.54K	0	0	--	--	Show Txns Hide Txns